Genome-wide CN analysis of the 13 intrinsic-resistant tumours revealed NRG1 and GNAS amplifications in CRC tumours without any aberrations in RAS/RAF pathway genes (Fig. 2a). This evidence concerns the gene NRG1 and colorectal carcinoma.